エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/03/04 | 2,206 | 2,208 | 2,112 | 2,159 | -71 | -3.2% | 44,500 |
2022/03/03 | 2,260 | 2,308 | 2,195 | 2,230 | +1 | ±0% | 21,000 |
2022/03/02 | 2,173 | 2,238 | 2,160 | 2,229 | -19 | -0.8% | 34,200 |
2022/03/01 | 2,155 | 2,259 | 2,154 | 2,248 | +124 | +5.8% | 40,600 |
2022/02/28 | 2,018 | 2,126 | 2,007 | 2,124 | +80 | +3.9% | 43,600 |
2022/02/25 | 1,895 | 2,044 | 1,885 | 2,044 | +212 | +11.6% | 71,000 |
2022/02/24 | 1,887 | 1,950 | 1,806 | 1,832 | -95 | -4.9% | 69,700 |
2022/02/22 | 1,950 | 2,008 | 1,910 | 1,927 | -53 | -2.7% | 39,000 |
2022/02/21 | 1,978 | 1,989 | 1,910 | 1,980 | -28 | -1.4% | 30,100 |
2022/02/18 | 1,942 | 2,020 | 1,888 | 2,008 | +26 | +1.3% | 45,000 |
2022/02/17 | 2,020 | 2,055 | 1,963 | 1,982 | -39 | -1.9% | 43,800 |
2022/02/16 | 2,010 | 2,053 | 1,978 | 2,021 | +51 | +2.6% | 68,100 |
2022/02/15 | 2,012 | 2,046 | 1,953 | 1,970 | -40 | -2% | 55,100 |
2022/02/14 | 2,051 | 2,142 | 2,000 | 2,010 | -432 | -17.7% | 139,400 |
2022/02/10 | 2,435 | 2,478 | 2,379 | 2,442 | +57 | +2.4% | 24,600 |
2022/02/09 | 2,291 | 2,389 | 2,263 | 2,385 | +94 | +4.1% | 16,800 |
2022/02/08 | 2,347 | 2,385 | 2,291 | 2,291 | -16 | -0.7% | 10,900 |
2022/02/07 | 2,384 | 2,404 | 2,290 | 2,307 | -94 | -3.9% | 19,000 |
2022/02/04 | 2,325 | 2,407 | 2,287 | 2,401 | +76 | +3.3% | 13,700 |
2022/02/03 | 2,453 | 2,453 | 2,311 | 2,325 | -128 | -5.2% | 20,100 |
2022/02/02 | 2,368 | 2,460 | 2,368 | 2,453 | +85 | +3.6% | 18,200 |
2022/02/01 | 2,403 | 2,467 | 2,331 | 2,368 | +24 | +1% | 24,600 |
2022/01/31 | 2,228 | 2,396 | 2,228 | 2,344 | +116 | +5.2% | 22,700 |
2022/01/28 | 2,219 | 2,278 | 2,158 | 2,228 | +48 | +2.2% | 67,900 |
2022/01/27 | 2,385 | 2,385 | 2,168 | 2,180 | -184 | -7.8% | 82,400 |
2022/01/26 | 2,352 | 2,423 | 2,305 | 2,364 | -4 | -0.2% | 30,900 |
2022/01/25 | 2,488 | 2,500 | 2,315 | 2,368 | -89 | -3.6% | 42,200 |
2022/01/24 | 2,418 | 2,473 | 2,383 | 2,457 | -11 | -0.4% | 29,600 |
2022/01/21 | 2,383 | 2,474 | 2,350 | 2,468 | +31 | +1.3% | 28,600 |
2022/01/20 | 2,327 | 2,482 | 2,327 | 2,437 | +116 | +5% | 28,500 |
2022/01/19 | 2,391 | 2,445 | 2,301 | 2,321 | -120 | -4.9% | 36,200 |
2022/01/18 | 2,440 | 2,510 | 2,415 | 2,441 | ±0 | ±0% | 21,700 |
2022/01/17 | 2,476 | 2,512 | 2,429 | 2,441 | -29 | -1.2% | 9,700 |
2022/01/14 | 2,400 | 2,486 | 2,360 | 2,470 | +42 | +1.7% | 30,000 |
2022/01/13 | 2,525 | 2,525 | 2,428 | 2,428 | -111 | -4.4% | 22,200 |
2022/01/12 | 2,488 | 2,539 | 2,473 | 2,539 | +122 | +5% | 18,900 |
2022/01/11 | 2,343 | 2,486 | 2,338 | 2,417 | +36 | +1.5% | 28,000 |
2022/01/07 | 2,449 | 2,499 | 2,327 | 2,381 | -54 | -2.2% | 40,800 |
2022/01/06 | 2,511 | 2,541 | 2,435 | 2,435 | -156 | -6% | 41,600 |
2022/01/05 | 2,652 | 2,662 | 2,589 | 2,591 | -98 | -3.6% | 32,400 |
2022/01/04 | 2,780 | 2,781 | 2,632 | 2,689 | -86 | -3.1% | 33,700 |
2021/12/30 | 2,830 | 2,830 | 2,747 | 2,775 | -80 | -2.8% | 17,800 |
2021/12/29 | 2,823 | 2,877 | 2,741 | 2,855 | +73 | +2.6% | 20,700 |
2021/12/28 | 2,760 | 2,791 | 2,705 | 2,782 | +54 | +2% | 18,500 |
2021/12/27 | 2,842 | 2,842 | 2,727 | 2,728 | -102 | -3.6% | 21,700 |
2021/12/24 | 2,742 | 2,938 | 2,742 | 2,830 | +89 | +3.2% | 45,200 |
2021/12/23 | 2,750 | 2,828 | 2,704 | 2,741 | +34 | +1.3% | 19,300 |
2021/12/22 | 2,604 | 2,792 | 2,604 | 2,707 | +123 | +4.8% | 51,300 |
2021/12/21 | 2,560 | 2,630 | 2,501 | 2,584 | +17 | +0.7% | 30,700 |
2021/12/20 | 2,645 | 2,669 | 2,561 | 2,567 | -92 | -3.5% | 22,100 |
851~
900
件表示中 / 1876件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 213,800円 | +10.2% | +15.1% | 1.64% | 15.24倍 | 2.19倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
サニーサイド | 68,000円 | +4.7% | +16.2% | 3.53% | 8.98倍 | 2.23倍 |
|
企業PRや販促支援(SP)主力。スポーツビジネスにも強み。人気朝食レストラン「ビルズ」展開 |
ブリーチ | 39,500円 | +0.2% | +1.6% | 0.00% | 32.70倍 | 1.06倍 |
|
成果報酬型の集客支援展開。当社が広告費負担するモデルに特徴。広告制作から運用まで内製 |
MDNT | 3,800円 | +21.1% | - | 0.00% | - | 2.27倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
トリドリ | 305,500円 | +31.1% | +60.2% | 0.00% | 25.07倍 | 6.02倍 |
|
インフルエンサーと企業をつなぐプラットフォーム展開。個人事業主向けサービスに注力中 |
市場注目の銘柄
チャート関連のコラム